Infectious Diseases News and Research

RSS

Study finds spread of multidrug-resistant S. Kentucky

A new study has identified the recent emergence of a multidrug-resistant strain of Salmonella that has a high level resistance to ciprofloxacin, a common treatment for severe Salmonella infections.

3 Aug 2011

Models should guide decision-making for HIV prevention strategies

Ronald Valdesarri, HHS deputy assistant secretary for health, infectious diseases, discusses a recent "two-day workshop on 'Modeling and Evidence-Based Decision Making' sponsored by amfAR, the Foundation for AIDS Research and cosponsored by the Kaiser Family Foundation, the National Alliance of State and Territorial AIDS Directors, and the Urban Coalition for HIV/AIDS Prevention Services" in this AIDS.gov blog post.

3 Aug 2011

OUP, PIDS partner to publish Journal of the Pediatric Infectious Diseases Society

Oxford University Press (OUP) will partner with the Pediatric Infectious Diseases Society (PIDS) to publish the Journal of the Pediatric Infectious Diseases Society.

3 Aug 2011

Hospitals not doing enough to encourage breastfeeding among new mothers: CDC report

According to a report by the U.S. Centers for Disease Control and Prevention (CDC), hospitals are not doing enough to encourage breastfeeding among new mothers.

3 Aug 2011

BD third quarter revenues increase to $2.014 billion

BD, a leading global medical technology company, today reported quarterly revenues of $2.014 billion for the third fiscal quarter ended June 30, 2011, representing an increase of 10.0 percent from the prior-year period.

From BD (Becton, Dickinson and Company) 2 Aug 2011

Meningococcal case at Townsville child care center

Meningococcal disease - a serious infectious disease affecting the brain and related organs - has been detected at a child care centre in Townsville, Queensland, where a medical student died of the illness last week. Queensland Health has confirmed a child at the centre has been admitted to hospital with meningococcal disease.

1 Aug 2011

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Cubist Pharmaceuticals, Inc. today announced the initiation of a pivotal Phase 3 trial of CXA-201 in patients with complicated urinary tract infections.

1 Aug 2011

PathoGenetiX receives $4.0 million in first close of Series B financing

PathoGenetiX Inc., today announced that the Company has received $4.0 million in the first closing of its Series B financing.

1 Aug 2011

New device can produce blood-based diagnostic results in minutes

Samuel K. Sia, assistant professor of biomedical engineering at Columbia Engineering, has developed an innovative strategy for an integrated microfluidic-based diagnostic device-in effect, a lab-on-a-chip-that can perform complex laboratory assays, and do so with such simplicity that these tests can be carried out in the most remote regions of the world.

1 Aug 2011

CDC, ZKBS classifies Advaxis Agents as non-pathogenic materials

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has received affirmation by the Public Health Service of the U. S. Centers for Disease Control and Prevention and the Zentrale Kommission für die Biologische Sicherheit, the Central Commission for Biological Safety in Germany, that Advaxis strains, constructs and immunotherapies have been attenuated to the point that they are classified as non-pathogenic materials for handling and shipment.

30 Jul 2011

Hospitals miss opportunities to diagnose patients infected with HIV in EDs: UC research

New University of Cincinnati research on HIV testing at local emergency departments shows that hospitals miss opportunities to diagnose patients who do not know they are infected with HIV, even when a regular testing program is in place.

30 Jul 2011

UH Case Medical Center to commence Phase 1 clinical trial on TMC207

University Hospitals Case Medical Center will begin a Phase 1 clinical trial on a new experimental anti-tuberculosis drug called TMC207.

30 Jul 2011

ELPA, WHA announce educational program for hepatitis B patients

The European Liver Patients Association (ELPA) and the World Hepatitis Alliance (WHA), announced today on the 4th annual World Hepatitis Day that 'PATH B - "Patients and Professionals Acting Together for Hepatitis B" - My journey with chronic hepatitis B', a comprehensive educational resource designed to improve the lives of people living with chronic hepatitis B, is to be launched in August 2011.

29 Jul 2011

MSNBC's Chris Matthews interviews NIAID head Anthony Fauci

The Center for Global Health Policy's "Science Speaks" blog features video of an interview of Anthony Fauci, director of the NIH National Institute of Allergy and Infectious Diseases, that was conducted by MSNBC "Hardball" host Chris Matthews at a Capitol Hill briefing on Tuesday, which was hosted by the Foundation for AIDS Research.

29 Jul 2011

Sorrento receives NIAID Phase I STTR grant to develop vaccines against C. difficile infection

Sorrento Therapeutics, Inc. announced today that it has received a Phase I Small Business Technology Transfer Research grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

29 Jul 2011

ELPA, WHA to launch PATH B programme for patients with chronic hepatitis B

28 Jul 2011

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced results of operations for the second quarter of 2011.

27 Jul 2011

UBC research projects receive CIHR grants to promote greater equity in global health

Three research projects at the University of British Columbia have won five-year grants totaling nearly $6 million from the Canadian Institutes of Health Research (CIHR) to promote greater equity in global health.

27 Jul 2011

Kadmon, Dyax enter license agreement for antibody phage display libraries

Dyax Corp. and Kadmon Corporation, LLC announced today that Dyax has granted Kadmon a non-exclusive license to Dyax's proprietary "gold-standard" antibody phage display libraries for the discovery and development of therapeutic antibodies.

26 Jul 2011

Physician-targeted education campaign reduces outpatient antibiotic use in Quebec

Antibiotic overuse and resistance have emerged as major threats during the past two decades. Following an outbreak of Clostridium difficile infections, which often result from antibiotic use, health care professionals in Quebec, Canada targeted physicians and pharmacists with an education campaign that reduced outpatient antibiotic use, according to a study published in Clinical Infectious Diseases and now available online.

26 Jul 2011